FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival Biotech Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against XL Fleet Corp., Bellus Health, Neptune Wellness, and Sequential Brands and Encourages Investors to Contact the Firm Biotech Investing
AbbVie Submits Regulatory Applications for SKYRIZI® in Psoriatic Arthritis to FDA and EMA Biotech Investing
AbbVie to Present Data Across its Robust Neuroscience Portfolio at the 2021 American Academy of Neurology Annual Meeting Biotech Investing
FDA Approves Bausch + Lomb ClearVisc Dispersive Ophthalmic Viscosurgical Device Medical Device Investing
Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
DEADLINE ALERT for XL, PLUG, NEPT, BLU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
Abbott's XIENCE Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy for High Bleeding Risk Patients Medical Device Investing
